BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26485987)

  • 1. [Influence of Tumor Microenvironment of Hepatocellular Carcinoma on the Proliferation of Vascular Endothelial Cells and Vascular Angiogenesis Ability].
    Xia Q; Yin H; Shen Y; Liu J; Yan Z; Hong J; Zhou F; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):612-7. PubMed ID: 26485987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model.
    Chiew GGY; Fu A; Perng Low K; Qian Luo K
    Sci Rep; 2015 Jun; 5():10801. PubMed ID: 26053957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
    Huang B; Huang M; Li Q
    Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.
    Cheng CC; Chao WT; Shih JH; Lai YS; Hsu YH; Liu YH
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):143-153. PubMed ID: 33860837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
    Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
    Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
    Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
    Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of low molecular weight heparin on the secretion of vascular endothelial growth factor by tumor cells in vitro].
    Sun Z; Hu ZL; Ning XH; Zhou JF; Shao YJ; Duan JH; Yang XD; Bai CM
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):826-30. PubMed ID: 20137346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study.
    Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G
    Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
    Wang H; Zhang C; Chi H; Meng Z
    Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
    Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y
    Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A.
    Lu Y; Lin N; Chen Z; Xu R
    Mol Med Rep; 2015 Jan; 11(1):691-7. PubMed ID: 25333351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis.
    Wang F; Fei H; Qi B; Yao S; Chang Z
    Mol Cell Biochem; 2012 May; 364(1-2):165-71. PubMed ID: 22209835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.